Smithfield Trust’s Evolent Health EVH Stock Holding History

Smithfield Trust’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6K	Buy	+2,735	New	+$8.68K	﹤0.01%	964
2021 Q1	–	Sell	-3,000	Closed	-$48K	–	1100
2020 Q4	$48K	Hold	3,000	–	–	﹤0.01%	531
2020 Q3	$37K	Hold	3,000	–	–	﹤0.01%	551
2020 Q2	$21K	Hold	3,000	–	–	﹤0.01%	615
2020 Q1	$16K	Buy	+3,000	New	+$26.8K	﹤0.01%	607
2017 Q3	–	Sell	-4,000	Closed	-$101K	–	811
2017 Q2	$101K	Hold	4,000	–	–	0.01%	408
2017 Q1	$89K	Hold	4,000	–	–	0.01%	425
2016 Q4	$59K	Hold	4,000	–	–	0.01%	490
2016 Q3	$98K	Hold	4,000	–	–	0.02%	389
2016 Q2	$77K	Hold	4,000	–	–	0.01%	427
2016 Q1	$42K	Buy	4,000 +2,000	+100%	+$20.7K	0.01%	508
2015 Q4	$24K	Buy	+2,000	New	+$29.5K	﹤0.01%	584

Other funds holding EVH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Smithfield Trust's EVH Position: Q1 2026 in Review

Smithfield Trust opened a new position in Evolent Health (EVH) in Q1 2026: 2,735 shares worth $6K. The stake represents ﹤0.01% of the portfolio and ranks #964 among its holdings. This is a return to the name: Smithfield Trust previously reported a position in EVH as recently as Q4 2020.

Smithfield Trust first reported a position in EVH in Q4 2015 and has held it in 12 quarters since. The position peaked at $101K in Q2 2017. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

Smithfield Trust held 2,735 shares of Evolent Health worth $6K as of Q1 2026.
Evolent Health was a new Smithfield Trust position in Q1 2026.
Evolent Health made up ﹤0.01% of Smithfield Trust's portfolio in Q1 2026, its #964 holding.
Smithfield Trust first reported a position in Evolent Health in Q4 2015 and has held it in 12 quarters since.
Smithfield Trust's Evolent Health position peaked at $101K in Q2 2017.
191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Smithfield Trust's 13F filing for Q1 2026, filed 8 May 2026.